Terumo Pharmaceutical Solutions (CDMO)

CDMO

Japan

https://www.terumopharmaceuticalsolutions.com/

Is this your company? Claim this profile

Drug Product

Analytical & Bioanalytical Services

Clinical Trial Supply & Logistics

Manufacturing & Lab Equipment

Regulatory, Tech Transfer & Support Services

Company Overview

About

Terumo Pharmaceutical Solutions (CDMO) is a pharmaceutical CDMO offering comprehensive services.

Key Expertise

Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals

Therapeutic Areas

Immunology

Rheumatology

Quick Facts

HQ:Japan

Founded:2016

Employees:1,411

Capabilities & Services

Core Capabilities

Peptide Synthesis
Small Molecule API
Formulation Development

Types of Organization

GMP Manufacturing

Quality Systems

Regulatory Support

Dosage Forms

Inhalation

Containment Capabilities

OEB 4 (1-10 µg/m³)

Production Scales

R&D / Pre-clinical

Lab Scale

Pilot Scale

Markets Served

Global

Regulatory Approvals

Drug Approval DN00GU

Health Canada · #APR-Z8HWVG2G · 2022-08-01

Drug Approval Z9GTPG

EMA · #APR-JMV0GDOL · 2019-12-01

Certifications

FDA Registration

U.S. Food and Drug Administration

Cert #: CERT-IA3U5ZET

Issued: 2020-09-02

Expires: 2025-03-09

MHRA GMP

UK Medicines and Healthcare products Regulatory Agency

Cert #: CERT-GJBV6LRJ

Issued: 2020-09-22

Expires: 2025-05-14

Loading CDMO intelligence...

Request an Introduction

Please log in to contact this provider.

Key facts about Terumo Pharmaceutical Solutions (CDMO)

Terumo Pharmaceutical Solutions (CDMO) is headquartered in Japan.
Terumo Pharmaceutical Solutions (CDMO) was founded in 2016.
Terumo Pharmaceutical Solutions (CDMO) has 1,411 employees.
Terumo Pharmaceutical Solutions (CDMO)'s capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.

Find CDMOs like Terumo Pharmaceutical Solutions (CDMO)

Directory pages this company appears in, each with the full list of matching manufacturers.

CDMOs in Japan CDMOs in Asia Small Molecule API CDMOs Formulation Development CDMOs Inhalation CDMOs OEB 4 (1-10 µg/m³) CDMOs

Key facts about Terumo Pharmaceutical Solutions (CDMO)

Terumo Pharmaceutical Solutions (CDMO) is headquartered in Japan.

Terumo Pharmaceutical Solutions (CDMO) was founded in 2016.

Terumo Pharmaceutical Solutions (CDMO) has 1,411 employees.

Terumo Pharmaceutical Solutions (CDMO)'s capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.